EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+7.08%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$303M
AUM Growth
+$303M
(+16%)
Cap. Flow
+$16.6M
Cap. Flow
% of AUM
5.48%
Top 10 Holdings %
Top 10 Hldgs %
78.52%
Holding
40
New
10
Increased
5
Reduced
8
Closed
7
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$19.8M |
| 2 |
Ascendis Pharma
ASND
|
$15.3M |
| 3 |
Aclaris Therapeutics
ACRS
|
$11.2M |
| 4 |
Editas Medicine
EDIT
|
$10.2M |
| 5 |
Xencor
XNCR
|
$9.87M |
Top Sells
| 1 |
DERM
Dermira, Inc.
DERM
|
$14.5M |
| 2 |
Cytokinetics
CYTK
|
$9.62M |
| 3 |
KA
Kineta, Inc. Common Stock
KA
|
$9.39M |
| 4 |
AKAO
Achaogen, Inc.
AKAO
|
$8.05M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$7.37M |
Sector Composition
| 1 | Healthcare | 90% |
| 2 | Industrials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ironwood Pharmaceuticals
IRWD
$214M
| $43.7M | 13.9% | 2,855,515 +45,200 | +2% | +$691K |
|
2
Galapagos
GLPG
$2.07B
| $36M | 11.47% | 561,341 +60,765 | +12% | +$3.9M |
|
3
Assembly Biosciences
ASMB
$190M
| $35.8M | 11.38% | 2,943,164 | – | – |
|
|
ALXN
4
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $19.8M | 6.32% | +162,200 | New | +$19.8M |
|
|
5
Ascendis Pharma
ASND
$11.8B
| $19.7M | 6.29% | 975,700 +756,500 | +345% | +$15.3M |
|
6
Ardelyx
ARDX
$1.53B
| $18.6M | 5.92% | 1,310,023 | – | – |
|
7
Kura Oncology
KURA
$686M
| $15.4M | 4.91% | 2,611,906 | – | – |
|
|
FPRX
8
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $15M | 4.77% | 298,712 +12,100 | +4% | +$606K |
|
9
FibroGen
FGEN
$47.8M
| $14.7M | 4.67% | 686,184 | – | – |
|
|
10
Aclaris Therapeutics
ACRS
$209M
| $11.2M | 3.58% | +414,000 | New | +$11.2M |
|
|
11
Editas Medicine
EDIT
$231M
| $10.2M | 3.24% | +626,762 | New | +$10.2M |
|
|
12
Xencor
XNCR
$580M
| $9.87M | 3.14% | +375,000 | New | +$9.87M |
|
|
CMRX
13
DELISTED
Chimerix, Inc.
CMRX
| $6.51M | 2.07% | 1,415,687 +817,625 | +137% | +$3.76M |
|
14
Fastenal
FAST
$57B
| $6.37M | 2.03% | +2,537,026 | New | +$6.37M |
|
15
Atara Biotherapeutics
ATRA
$84.6M
| $3.07M | 0.98% | +215,812 | New | +$3.07M |
|
16
Adverum Biotechnologies
ADVM
$64.6M
| $2.54M | 0.81% | 874,447 -71,816 | -8% | -$208K |
|
|
KIN
17
DELISTED
Kindred Biosciences, Inc.
KIN
| $2.43M | 0.77% | 571,126 -861,639 | -60% | -$3.66M |
|
|
ATYR
18
aTyr Pharma
ATYR
$527M
| $2.1M | 0.67% | +976,986 | New | +$2.1M |
|
19
Syndax Pharmaceuticals
SNDX
$1.41B
| $1.96M | 0.63% | 273,862 -83,503 | -23% | -$599K |
|
|
EGLT
20
DELISTED
Egalet Corporation
EGLT
| $1.7M | 0.54% | +222,300 | New | +$1.7M |
|
|
NBRV
21
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $1.58M | 0.5% | 264,773 -284,139 | -52% | -$1.69M |
|
|
DERM
22
DELISTED
Dermira, Inc.
DERM
| $1.31M | 0.42% | 43,200 -478,800 | -92% | -$14.5M |
|
|
23
Agios Pharmaceuticals
AGIO
$2.19B
| $972K | 0.31% | 23,300 -176,700 | -88% | -$7.37M |
|
|
SYRS
24
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $773K | 0.25% | 63,596 | – | – |
|
|
25
Cytokinetics
CYTK
$4.23B
| $667K | 0.21% | 54,879 -791,775 | -94% | -$9.62M |
|